OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
| OPK Stock | USD 1.47 0.03 2.00% |
About 61% of Opko Health's investor base is looking to short. The analysis of the overall investor sentiment regarding Opko Health suggests that many traders are alarmed. Opko Health's investing sentiment shows overall attitude of investors towards Opko Health.
Opko |
MIAMI, Feb. 22, 2024 -- OPKO Health, Inc. plans to report operating and financial results for the three and 12 months ended December 31, 2023 after the close of the U.S. financial markets on Tuesday, February 27, 2024. OPKOs senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on February 27th beginning at 430 p.m. Eastern time. CONFERENCE CALL WEBCAST INFORMATION OPKO
Read at finance.yahoo.com
 |
Opko Health Fundamental Analysis
We analyze Opko Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Opko Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Opko Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Opko Health is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Opko Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Opko Health stock to make a market-neutral strategy. Peer analysis of Opko Health could also be used in its relative valuation, which is a method of valuing Opko Health by comparing valuation metrics with similar companies.
Peers
Opko Health Related Equities
| TTOO | T2 Biosystms | 8.70 | ||||
| GH | Guardant Health | 4.59 | ||||
| TWST | Twist Bioscience | 1.83 | ||||
| CDNA | Caredx | 1.03 | ||||
| IDXX | IDEXX Laboratories | 0.41 | ||||
| NTRA | Natera | 0.06 | ||||
| A | Agilent Technologies | 0.1 | ||||
| ME | 23Andme Holding | 0.28 | ||||
| CSTL | Castle Biosciences | 0.45 | ||||
| FLGT | Fulgent Genetics | 3.80 | ||||
| ILMN | Illumina | 3.99 | ||||
| BDSX | Biodesix | 10.00 |
Check out Opko Health Hype Analysis, Opko Health Correlation and Opko Health Performance. For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.